Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kunath, Frank"" wg kryterium: Autor


Tytuł:
Improving the Quality of Care for Cancer Patients through Oncological Second Opinions in a Comprehensive Cancer Center: Feasibility of Patient-Initiated Second Opinions through a Health-Insurance Service Point.
Autorzy:
Schulmeyer, Carla E.
Beckmann, Matthias W.
Fasching, Peter A.
Häberle, Lothar
Golcher, Henriette
Kunath, Frank
Wullich, Bernd
Emons, Julius
Pokaż więcej
Temat:
CANCER patient care
CANCER patients
SURGERY
METROPOLITAN areas
THERAPEUTICS
Źródło:
Diagnostics (2075-4418); Nov2023, Vol. 13 Issue 21, p3300, 12p
Terminy geograficzne:
GERMANY
Czasopismo naukowe
Tytuł:
Ureterovesical Anastomosis Complications in Kidney Transplantation: Definition, Risk Factor Analysis, and Prediction by Quantitative Fluorescence Angiography with Indocyanine Green.
Autorzy:
Gerken ALH; Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.
Nowak K; Department of Surgery, RoMed Hospital Rosenheim, Pettenkoferstraße 10, D-83022 Rosenheim, Germany.
Meyer A; Department of Vascular Surgery, Friedrich Alexander University Erlangen-Nuremberg, Krankenhausstraße 12, D-91054 Erlangen, Germany.
Kriegmair MC; Department of Urology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.
Weiss C; Department of Biometry and Statistics, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.
Krämer BK; Department of Medicine V, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.; European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, Ludolf-Krehl-Straße 13-17, D-68167 Mannheim, Germany.
Glossner P; Department of Vascular Surgery, Friedrich Alexander University Erlangen-Nuremberg, Krankenhausstraße 12, D-91054 Erlangen, Germany.
Heller K; Department of Nephrology, Friedrich Alexander University Erlangen-Nuremberg, Krankenhausstraße 12, D-91054 Erlangen, Germany.
Karampinis I; Division of Thoracic Surgery, Academic Thoracic Center Mainz, University Medical Center Mainz, Johannes Gutenberg University Mainz, Langenbeckstr. 1, D-55131 Mainz, Germany.
Kunath F; Department of Urology and Pediatric Urology, Friedrich Alexander University Erlangen-Nuremberg, Krankenhausstraße 12, D-91054 Erlangen, Germany.
Rahbari NN; Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.
Schwenke K; Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.; European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, Ludolf-Krehl-Straße 13-17, D-68167 Mannheim, Germany.
Reissfelder C; Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.; DKFZ Hector Cancer Institute, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.
Lang W; Department of Vascular Surgery, Friedrich Alexander University Erlangen-Nuremberg, Krankenhausstraße 12, D-91054 Erlangen, Germany.
Rother U; Department of Vascular Surgery, Friedrich Alexander University Erlangen-Nuremberg, Krankenhausstraße 12, D-91054 Erlangen, Germany.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2022 Nov 07; Vol. 11 (21). Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial.
Autorzy:
Schlichtig K; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.
Cuba L; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Pharmacy Department, Erlangen University Hospital, 91054 Erlangen, Germany.
Dürr P; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Pharmacy Department, Erlangen University Hospital, 91054 Erlangen, Germany.
Bellut L; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Urology and Pediatric Urology, Erlangen University Hospital, 91054 Erlangen, Germany.
Meidenbauer N; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Internal Medicine 5, Hematology and Oncology, Erlangen University Hospital, 91054 Erlangen, Germany.
Kunath F; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Urology and Pediatric Urology, Erlangen University Hospital, 91054 Erlangen, Germany.
Goebell PJ; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Urology and Pediatric Urology, Erlangen University Hospital, 91054 Erlangen, Germany.
Mackensen A; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Internal Medicine 5, Hematology and Oncology, Erlangen University Hospital, 91054 Erlangen, Germany.
Dörje F; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Pharmacy Department, Erlangen University Hospital, 91054 Erlangen, Germany.
Fromm MF; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.
Wullich B; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Urology and Pediatric Urology, Erlangen University Hospital, 91054 Erlangen, Germany.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2022 Aug 04; Vol. 11 (15). Date of Electronic Publication: 2022 Aug 04.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer.
Autorzy:
Sibert, Nora Tabea
Pfaff, Holger
Breidenbach, Clara
Wesselmann, Simone
Roth, Rebecca
Feick, Günther
Carl, Günter
Dieng, Sebastian
Gaber, Amr A.
Blana, Andreas
Darr, Christopher
Distler, Florian
Kunath, Frank
Bedke, Jens
Erdmann, Jörg
Minner, Jörg
Simon, Jörg
Kwiatkowski, Maciej
Burchardt, Martin
Harz, Nino
Pokaż więcej
Temat:
RADICAL prostatectomy
PROSTATE cancer
MATERIALS analysis
REGRESSION analysis
Źródło:
World Journal of Urology; Jun2022, Vol. 40 Issue 6, p1437-1446, 10p
Czasopismo naukowe
Tytuł:
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer.
Autorzy:
Sikic, Danijel (AUTHOR)
Eckstein, Markus (AUTHOR)
Weyerer, Veronika (AUTHOR)
Kubon, Jennifer (AUTHOR)
Breyer, Johannes (AUTHOR)
Roghmann, Florian (AUTHOR)
Kunath, Frank (AUTHOR)
Keck, Bastian (AUTHOR)
Erben, Philipp (AUTHOR)
Hartmann, Arndt (AUTHOR)
Wirtz, Ralph M. (AUTHOR)
Wullich, Bernd (AUTHOR)
Taubert, Helge (AUTHOR)
Wach, Sven (AUTHOR)
Pokaż więcej
Źródło:
Urologic Oncology. Feb2022, Vol. 40 Issue 2, p63.e9-63.e18. 1p.
Czasopismo naukowe
Tytuł:
Determinants of self-reported functional status (EPIC-26) in prostate cancer patients prior to treatment.
Autorzy:
Roth, Rebecca (AUTHOR)
Dieng, Sebastian (AUTHOR)
Oesterle, Alisa (AUTHOR)
Feick, Günter (AUTHOR)
Carl, Günther (AUTHOR)
Hinkel, Andreas (AUTHOR)
Steiner, Thomas (AUTHOR)
Kaftan, Björn Theodor (AUTHOR)
Kunath, Frank (AUTHOR)
Hadaschik, Boris (AUTHOR)
Oostdam, Simba-Joshua (AUTHOR)
Palisaar, Rein Jüri (AUTHOR)
Koralewski, Mateusz (AUTHOR)
Beyer, Burkhard (AUTHOR)
Haben, Björn (AUTHOR)
Tsaur, Igor (AUTHOR)
Wesselmann, Simone (AUTHOR)
Kowalski, Christoph (AUTHOR)
Pokaż więcej
Źródło:
World Journal of Urology. 2021, Vol. 39 Issue 1, p27-36. 10p.
Czasopismo naukowe
Tytuł:
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review.
Autorzy:
Schmidt S; für Urologie, Berlin, Germany.
Kunath F; für Urologie, Berlin, Germany.; Department of Urology, University Hospital Erlangen, Erlangen, Germany.
Coles B; Velindre NHS Trust, Cardiff University Library Services, Cardiff, United Kingdom.
Draeger DL; für Urologie, Berlin, Germany.; Department of Urology, University of Rostock, Rostock, Germany.
Krabbe LM; für Urologie, Berlin, Germany.; Department of Urology, University of Muenster Medical Center, Muenster, Germany.
Dersch R; Clinic of Neurology and Neurophysiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Kilian S; Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
Jensen K; Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
Dahm P; Urology Section, Minneapolis VA Health Care System, Minneapolis, MN, USA.; Department of Urology, University of Minnesota, Minneapolis, MN, USA.
Meerpohl JJ; Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany.
Pokaż więcej
Źródło:
Investigative and clinical urology [Investig Clin Urol] 2020 Jul; Vol. 61 (4), pp. 349-354. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji:
Comparative Study; Journal Article; Review
MeSH Terms:
Adjuvants, Immunologic/*administration & dosage
Antibiotics, Antineoplastic/*administration & dosage
BCG Vaccine/*administration & dosage
Mitomycin/*administration & dosage
Urinary Bladder Neoplasms/*drug therapy
Administration, Intravesical ; Humans ; Neoplasm Staging ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł:
Use of psycho-oncological services by prostate cancer patients: A multilevel analysis.
Autorzy:
Breidenbach C; German Cancer Society, Berlin, Germany.
Roth R; Institute of Medical Statistics and Computational Biology (IMSB), Faculty of Medicine, University of Cologne, Koln, Germany.
Ansmann L; Organizational Health Services Research, Department for Health Services Research, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.
Wesselmann S; German Cancer Society, Berlin, Germany.
Dieng S; OnkoZert GmbH, Neu-Ulm, Germany.
Carl EG; Federal Association of German Prostate Cancer Patient Support Groups, Bonn, Germany.
Feick G; Federal Association of German Prostate Cancer Patient Support Groups, Bonn, Germany.
Oesterle A; OnkoZert GmbH, Neu-Ulm, Germany.
Bach P; Kliniken Rhein-Ruhr, Herne, Germany.
Beyer B; Martini-Klinik Prostate Cancer Center Hamburg, Hamburg, Germany.
Borowitz R; Klinikum Memmingen, Memmingen, Germany.
Erdmann J; Caritas-Krankenhaus, Bad Mergentheim, Germany.
Kunath F; University Hospital Erlangen, Erlangen, Germany.
Oostdam SJ; KRH Klinikum Siloah, Hannover, Germany.
Tsaur I; University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
Zengerling F; University Hospital Ulm, Ulm, Germany.
Kowalski C; German Cancer Society, Berlin, Germany.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2020 Jun; Vol. 9 (11), pp. 3680-3690. Date of Electronic Publication: 2020 Mar 31.
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Psychosocial Support Systems*
Androgen Antagonists/*therapeutic use
Prostatectomy/*methods
Prostatic Neoplasms/*psychology
Psychotherapy/*methods
Adult ; Aged ; Aged, 80 and over ; Combined Modality Therapy ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Multilevel Analysis ; Prognosis ; Prospective Studies ; Prostatic Neoplasms/therapy ; Psycho-Oncology ; Watchful Waiting
Czasopismo naukowe
Tytuł:
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy.
Autorzy:
Sikic D; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Eckstein M; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Wirtz RM; STRATIFYER Molecular Pathology GmbH, 50935 Cologne, Germany.
Jarczyk J; Department of Urology, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Worst TS; Department of Urology, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Porubsky S; Institute of Pathology, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Keck B; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Kunath F; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Weyerer V; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Breyer J; Department of Urology, University of Regensburg, 93053 Regensburg, Germany.
Otto W; Department of Urology, University of Regensburg, 93053 Regensburg, Germany.
Rinaldetti S; Department of Hematology and Oncology, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Bolenz C; Department of Urology and Pediatric Urology, University Hospital Ulm, 89081 Ulm, Germany.
Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Wullich B; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Erben P; Department of Urology, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2020 Apr 02; Vol. 9 (4). Date of Electronic Publication: 2020 Apr 02.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance--protocol for a systematic review.
Autorzy:
Kunath F; Department of Urology, University Hospital of Erlangen, Erlangen, Germany. frank.kunath@uk-erlangen.de.; für Urologie, Berlin, Germany. frank.kunath@uk-erlangen.de.
Spek A; Department of Urology, University Hospital of Munich, Munich, Germany. .; für Urologie, Berlin, Germany. .
Jensen K; Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany. .
Zengerling F; Department of Urology, University Hospital of Ulm, Ulm, Germany. .; für Urologie, Berlin, Germany. .
Schmidt S; für Urologie, Berlin, Germany. .
Pokaż więcej
Źródło:
Systematic reviews [Syst Rev] 2015 Dec 18; Vol. 4, pp. 182. Date of Electronic Publication: 2015 Dec 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasms, Germ Cell and Embryonal/*pathology
Seminoma/*pathology
Testicular Neoplasms/*pathology
Humans ; Male ; Neoplasm Staging ; Neoplasms, Germ Cell and Embryonal/therapy ; Prognosis ; Recurrence ; Research Design ; Risk Factors ; Seminoma/therapy ; Systematic Reviews as Topic ; Testicular Neoplasms/therapy
SCR Disease Name:
Testicular Germ Cell Tumor
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies